SUBSCRIBERS

Biopharma firm AbbVie opens S$400m biologics plant in Tuas

The 120,000-sq metre facility, its first manufacturing plant in Asia, will create 250 jobs

Published Wed, Oct 4, 2017 · 09:50 PM

Singapore

GLOBAL research and development-based bio-pharmaceutical company AbbVie has enlarged its footprint in Singapore.

On Wednesday, it opened a new biologics manufacturing plant in Tuas, which will expand its manufacturing capabilities for biologics, which are commercial products derived from biotechnology. (Vaccines are one example.)

The biologics plant, located in Tuas Biomedical Park, comes in addition to AbbVie's existing small-molecule active pharmaceutical ingredients (API) facility.

The…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes